









市場
/
株式
/
nasdaq-lnth
/

Lantheus Holdings Inc

LNTH

64.890USD

+0.030+0.05%

終値 02/06, 16:00（ET）15分遅れの株価

4.30B時価総額

26.34直近12ヶ月PER



Lantheus Holdings Inc

64.890

+0.030+0.05%

概要金融分析企業名

概要

金融

分析

企業名

詳細情報 Lantheus Holdings Inc 企業名

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Lantheus Holdings Incの企業情報



企業コードLNTH

会社名Lantheus Holdings Inc

上場日Jun 25, 2015

最高経営責任者「CEO」Markison (Brian A)

従業員数808

証券種類Ordinary Share

決算期末Jun 25

本社所在地331 Treble Cove Road

都市NORTH BILLERICA

証券取引所NASDAQ OMX - NASDAQ BASIC

国United States of America

郵便番号01862

電話番号19786718001

ウェブサイトhttps://www.lantheus.com/

企業コードLNTH

上場日Jun 25, 2015

最高経営責任者「CEO」Markison (Brian A)

Lantheus Holdings Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Mary Anne Heino

Executive Chairman of the Board, Interim Executive Officer

599.01K

+14285.00%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+60654.00%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-17901.00%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+2537.00%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+2141.00%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+2537.00%

Dr. Phuong Khanh (P. K.) Morrow, M.D.

Independent Director

3.10K

+2537.00%

Mr. Samuel R. (Sam) Leno

Independent Director

Ms. Julie H. Mchugh

Lead Independent Director

Mr. Gary John Pruden

Independent Director

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Ms. Mary Anne Heino

Executive Chairman of the Board, Interim Executive Officer

599.01K

+14285.00%

Mr. Brian A. Markison

Chief Executive Officer, Director

232.42K

+60654.00%

Dr. Jean-Claude Provost, M.D.

Chief Scientific Officer

38.84K

-17901.00%

Dr. James H. (Jim) Thrall

Independent Director

35.74K

+2537.00%

Dr. Gerard Ber, Ph.D.

Independent Director

23.36K

+2141.00%

Ms. Minnie Baylor-Henry, J.D.

Independent Director

9.90K

+2537.00%

収益内訳

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

事業別USD

会社名

収益

比率

PYLARIFY

240.62M

0.00%

DEFINITY

81.78M

0.00%

TechneLite

21.13M

0.00%

Neuraceq

20.44M

0.00%

Strategic partnerships and other

13.71M

0.00%

Other precision diagnostics

6.34M

0.00%

会社から関連データがまだ開示されていません。

事業別

地域別

事業別USD

会社名

収益

比率

PYLARIFY

240.62M

0.00%

DEFINITY

81.78M

0.00%

TechneLite

21.13M

0.00%

Neuraceq

20.44M

0.00%

Strategic partnerships and other

13.71M

0.00%

Other precision diagnostics

6.34M

0.00%

株主

更新時刻: Sun, Jan 11

株主統計

種類

株主統計

比率

BlackRock Institutional Trust Company, N.A.

11.00%

Janus Henderson Investors

10.08%

The Vanguard Group, Inc.

10.06%

Morgan Stanley & Co. LLC

5.55%

Farallon Capital Management, L.L.C.

5.24%

他の

58.08%

株主統計

比率

BlackRock Institutional Trust Company, N.A.

11.00%

Janus Henderson Investors

10.08%

The Vanguard Group, Inc.

10.06%

Morgan Stanley & Co. LLC

5.55%

Farallon Capital Management, L.L.C.

5.24%

他の

58.08%

種類

株主統計

比率

Investment Advisor

51.50%

Investment Advisor/Hedge Fund

36.38%

Research Firm

8.68%

Hedge Fund

8.11%

Individual Investor

2.40%

Pension Fund

1.78%

Sovereign Wealth Fund

0.77%

Bank and Trust

0.72%

Family Office

0.13%

機関投資家保有株



更新時刻: Thu, Jan 1

報告期間

機関投資家数

保有株式数

比率

変動額

2025Q4

1029

71.74M

108.19%

-15.56M

2025Q3

1018

78.96M

119.07%

-8.67M

2025Q2

1039

82.20M

120.88%

-4.84M

2025Q1

1066

83.20M

120.27%

-2.89M

2024Q4

1033

78.65M

114.86%

-4.64M

2024Q3

1003

73.69M

106.06%

-7.92M

2024Q2

959

71.82M

103.63%

-10.29M

2024Q1

912

71.21M

103.87%

-11.25M

2023Q4

868

73.50M

107.32%

-9.24M

2023Q3

828

74.80M

109.31%

-3.81M

詳細を見る

株主動向



会社名

保有株式数

比率

変動額

変動率

日付

BlackRock Institutional Trust Company, N.A.

7.29M

11%

-208.45K

-2.78%

Sep 30, 2025

Janus Henderson Investors

6.68M

10.08%

-254.25K

-3.66%

Sep 30, 2025

The Vanguard Group, Inc.

6.92M

10.44%

+100.16K

+1.47%

Sep 30, 2025

Morgan Stanley & Co. LLC

3.68M

5.55%

+3.18M

+635.59%

Sep 30, 2025

Farallon Capital Management, L.L.C.

3.48M

5.24%

+161.00K

+4.85%

Sep 30, 2025

Fidelity Management & Research Company LLC

3.10M

4.68%

-1.03M

-24.93%

Sep 30, 2025

State Street Investment Management (US)

2.50M

3.77%

-61.59K

-2.41%

Sep 30, 2025

Geode Capital Management, L.L.C.

1.75M

2.65%

-22.43K

-1.26%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

1.37M

2.07%

-12.04K

-0.87%

Sep 30, 2025

Reinhart Partners, LLC

1.35M

2.03%

-55.90K

-3.98%

Sep 30, 2025

詳細を見る

配当金



過去5年間の配当金総支払額は 0.00 米ドルである。

日付

配当金

権利確定日

支払日

配当落ち日

データなし

株式分割



日付

配当落ち日

種類

比率

データなし

日付

配当落ち日

種類

比率

データなし

KeyAI



Lantheus Holdings Inc

詳細情報 Lantheus Holdings Inc 企業名

Lantheus Holdings Incの企業情報

Lantheus Holdings Incの経営陣

収益内訳

株主

機関投資家保有株

株主動向

関連ETF

配当金

株式分割